147 related articles for article (PubMed ID: 16102824)
1. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
Xiao Z; Zhang M; Liu X; Zhang Y; Yang L; Hao Y
Leuk Res; 2006 Mar; 30(3):332-4. PubMed ID: 16102824
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and laboratory study of 4 cases of myelodysplastic syndromes with t (1;3) (p36; q21)].
Zhang MR; Liu XP; Zhang Y; Yang L; Zhou XH; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):99-102. PubMed ID: 16732963
[TBL] [Abstract][Full Text] [Related]
3. Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1.
Xinh PT; Tri NK; Nagao H; Nakazato H; Taketazu F; Fujisawa S; Yagasaki F; Chen YZ; Hayashi Y; Toyoda A; Hattori M; Sakaki Y; Tokunaga K; Sato Y
Genes Chromosomes Cancer; 2003 Mar; 36(3):313-6. PubMed ID: 12557231
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
Lahortiga I; Agirre X; Belloni E; Vázquez I; Larrayoz MJ; Gasparini P; Lo Coco F; Pelicci PG; Calasanz MJ; Odero MD
Oncogene; 2004 Jan; 23(1):311-6. PubMed ID: 14712237
[TBL] [Abstract][Full Text] [Related]
5. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation.
Nishikata I; Sasaki H; Iga M; Tateno Y; Imayoshi S; Asou N; Nakamura T; Morishita K
Blood; 2003 Nov; 102(9):3323-32. PubMed ID: 12816872
[TBL] [Abstract][Full Text] [Related]
6. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
[TBL] [Abstract][Full Text] [Related]
7. t(1;3)(p36;p21) is a recurring therapy-related translocation.
Sato Y; Izumi T; Kanamori H; Davis EM; Miura Y; Larson RA; Le Beau MM; Ozawa K; Rowley JD
Genes Chromosomes Cancer; 2002 Jun; 34(2):186-92. PubMed ID: 11979552
[TBL] [Abstract][Full Text] [Related]
8. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
[TBL] [Abstract][Full Text] [Related]
9. [Chromosomal structural changes in patients with myelodysplastic syndrome].
Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
[TBL] [Abstract][Full Text] [Related]
10. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.
Mochizuki N; Shimizu S; Nagasawa T; Tanaka H; Taniwaki M; Yokota J; Morishita K
Blood; 2000 Nov; 96(9):3209-14. PubMed ID: 11050005
[TBL] [Abstract][Full Text] [Related]
11. A case of atypical myelodysplastic syndrome with a novel reciprocal translocation t(1;12)(q21;p13).
Sánchez J; Serrano J; Román J; García JM; Nomdedéu J; Torres A
Haematologica; 2000 Apr; 85(4):434-5. PubMed ID: 10756375
[No Abstract] [Full Text] [Related]
12. Waldenström's macroglobulinemia with the AML/MDS-associated t(1;3)(p36;q21).
Johansson B; Waldenström J; Hasselblom S; Mitelman F
Leukemia; 1995 Jul; 9(7):1136-8. PubMed ID: 7630185
[TBL] [Abstract][Full Text] [Related]
13. A novel t(1;12)(q21;q24) in a patient with myelodysplastic syndrome.
Park TS; Lee SG; Song J; Kim JS; Choi JR
Ann Hematol; 2010 May; 89(5):513-6. PubMed ID: 19697027
[No Abstract] [Full Text] [Related]
14. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
Lin P; Medeiros LJ; Yin CC; Abruzzo LV
Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
[TBL] [Abstract][Full Text] [Related]
15. A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome.
Coccaro N; Brunetti C; Tota G; Pierri CL; Anelli L; Zagaria A; Casieri P; Impera L; Minervini CF; Minervini A; Cumbo C; Ricco A; Carluccio P; Orsini P; Specchia G; Albano F
Leuk Lymphoma; 2018 Apr; 59(4):996-999. PubMed ID: 28718702
[No Abstract] [Full Text] [Related]
16. Gain of 1q in pediatric myelodysplastic syndromes.
Morerio C; Rapella A; Tassano E; Lanino E; Micalizzi C; Rosanda C; Panarello C
Leuk Res; 2006 Nov; 30(11):1437-41. PubMed ID: 16472857
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
Qian J; Chen Z; Wang W; Cen J; Xue Y
Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
[TBL] [Abstract][Full Text] [Related]
18. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
Xiao B; Li JY; Pan JL; Ma L; Qiu HR; Wu YF; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):513-6. PubMed ID: 16468325
[TBL] [Abstract][Full Text] [Related]
19. A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene.
Zagaria A; Anelli L; Coccaro N; Casieri P; Minervini A; Buttiglione V; Ricco A; Specchia G; Albano F
Leuk Res; 2012 Jul; 36(7):852-6. PubMed ID: 22365942
[TBL] [Abstract][Full Text] [Related]
20. Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation.
Nishikata I; Nakahata S; Saito Y; Kaneda K; Ichihara E; Yamakawa N; Morishita K
Oncogene; 2011 Oct; 30(40):4194-207. PubMed ID: 21516122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]